Achim Rosemann
Impact in
- Health Informatics top 10%
Papers in
- Physiology 23
- Biomedical Ethics and Regulation 23
-
- Pluripotent Stem Cells Research 14
- CRISPR and Genetic Engineering 3
- Co-authors
- Margaret Sleeboom‐Faulkner (6 shared papers)Xinqing Zhang (3 shared papers)Susan Molyneux‐Hodgson (2 shared papers)Bernd Carsten Stahl (3 shared papers)Li Jiang (1 shared paper)Michele Farisco (4 shared papers)Inga Ulnicane (3 shared papers)Arleen Salles (3 shared papers)
- Journals
- Regenerative Medicine (4 papers)Science and Public Policy (2 papers)Journal of Responsible Innovation (2 papers)Science as Culture (2 papers)Social Science & Medicine (2 papers)
- Partner nations
- United KingdomChinaSweden
In The Last Decade
Achim Rosemann
29 papers receiving 308 citations
Peers
Comparison fields: 5 of 100
- Health Informatics 16
- Business and International Management 16
- Reproductive Medicine 62
- Physiology 145
- Management of Technology and Innovation 20
Countries citing papers authored by Achim Rosemann
This map shows the geographic impact of Achim Rosemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Rosemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Rosemann more than expected).
Fields of papers citing papers by Achim Rosemann
This network shows the impact of papers produced by Achim Rosemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Rosemann. The network helps show where Achim Rosemann may publish in the future.
Co-authors
The 25 scholars most cited alongside Achim Rosemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 48 | |
| 2 | 2016 | 27 | |
| 3 | 2015 | 25 | |
| 4 | 2016 | 24 | |
| 5 | 2015 | 19 | |
| 6 | 2014 | 19 | |
| 7 | 2019 | 15 | |
| 8 | 2021 | 15 | |
| 9 | 2014 | 14 | |
| 10 | 2006 | 12 | |
| 11 | 2013 | 11 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 10 | |
| 14 | 2018 | 9 | |
| 15 | 2015 | 8 | |
| 16 | 2018 | 7 | |
| 17 | 2018 | 7 | |
| 18 | 2021 | 5 | |
| 19 | 2019 | 5 | |
| 20 | 2017 | 5 |
About Achim Rosemann
Achim Rosemann is a scholar working on Physiology, Molecular Biology, Reproductive Medicine, Public Health, Environmental and Occupational Health and Cognitive Neuroscience, having authored 32 papers that have together received 324 indexed citations. Recurring topics across this work include Biomedical Ethics and Regulation (23 papers), Pluripotent Stem Cells Research (14 papers), Science, Research, and Medicine (11 papers), Ethics in Clinical Research (6 papers), Neuroethics, Human Enhancement, Biomedical Innovations (5 papers), CRISPR and Genetic Engineering (3 papers), Ethics and Social Impacts of AI (2 papers) and Reproductive Health and Technologies (2 papers). The work is most often cited by research in Health Informatics (16 citations), Business and International Management (16 citations), Reproductive Medicine (62 citations), Physiology (145 citations) and Management of Technology and Innovation (20 citations). Achim Rosemann has collaborated with scholars based in United Kingdom, China and Sweden. Frequent co-authors include Margaret Sleeboom‐Faulkner, Xinqing Zhang, Susan Molyneux‐Hodgson, Bernd Carsten Stahl, Li Jiang, Michele Farisco, Inga Ulnicane, Arleen Salles, Simisola Akintoye and Sven Nyholm. Their work appears in journals such as Regenerative Medicine, Science and Public Policy, Journal of Responsible Innovation, Science as Culture and Social Science & Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.